联化科技股份有限公司 《公司章程》修订对照表 联化科技股份有限公司（以下简称"公司"）第八届董事会第二十五次会议 审议通过了《关于修订<公司章程>等制度的议案》，同意对《公司章程》相关内 容进行修订，此议案需提交2025年第一次临时股东大会审议。本次变更具体内容 最终以浙江省市场监督管理局的核准登记为准。 《公司章程》相关条款中所述"股东大会"统一修订为"股东会"，若原《公 司章程》的相关条款仅涉及前述修订，不再逐条列示。 此外，本次章程修订涉及删除及新增条款，章程后续条款及引用条款序号相 应调整及《公司章程》中其他非实质性修订，如标点符号调整等也不再逐条列示。 具体修订内容如下： | 序号 | 修订前条款 | 修订后条款 | | --- | --- | --- | | 1 | 第一条 为维护联化科技股份有限公 | 第一条 为维护联化科技股份有限公 | | | 司（以下简称"公司"）、公司股东和债权 | 司（以下简称"公司"）、公司股东、职工 | | | 人的合法权益，规范公司的组织和行为， | 和债权人的合法权益，规范公司的组织和 | | | 根据《中国共产党章程》、《中华人民共 | 行为，根据《中国共产党 ...

证券代码：002250 证券简称：联化科技 联化科技股份有限公司独立董事提名人声明与承诺 提名人联化科技股份有限公司董事会现就提名_ Zhang Yun__为联化科技股 份有限公司第九届董事会独立董事候选人发表公开声明。被提名人已书面同意 作为联化科技股份有限公司第九届董事会独立董事候选人（参见该独立董事候 选人声明）。本次提名是在充分了解被提名人职业、学历、职称、详细的工作 经历、全部兼职、有无重大失信等不良记录等情况后作出的，本提名人认为被 提名人符合相关法律、行政法规、部门规章、规范性文件和深圳证券交易所业 务规则对独立董事候选人任职资格及独立性的要求，具体声明并承诺如下事 项： 一、被提名人已经通过联化科技股份有限公司第八届董事会提名委员会或 者独立董事专门会议资格审查，提名人与被提名人不存在利害关系或者其他可 能影响独立履职情形的密切关系。 ☑ 是 □否 如否，请详细说明： 二、被提名人不存在《中华人民共和国公司法》第一百七十八条等规定不 得担任公司董事的情形。 ☑ 是 □否 如否，请详细说明： 三、被提名人符合中国证监会《上市公司独立董事管理办法》和深圳证券 交易所业务规则规定的独立董事任职资格和 ...

2、股东大会的召集人：联化科技股份有限公司（以下简称"公司"、"联化 科技"）第八届董事会第二十五次会议决议提请召开股东大会。 证券代码：002250 证券简称：联化科技 公告编号：2025-039 联化科技股份有限公司 关于召开 2025 年第一次临时股东大会的通知 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、召开会议基本情况 1、股东大会届次：2025年第一次临时股东大会 3、会议召开的合法、合规性：本次股东大会会议的召集、召开符合有关法 律、行政法规、部门规章、规范性文件和《公司章程》的规定。 4、会议召开的日期、时间： 现场会议时间为：2025年9月16日（星期二）15时00分 网络投票时间为：2025年9月16日 其中，通过深圳证券交易所交易系统进行网络投票的具体时间为：2025年9 月16日9:15至9:25，9:30至11:30和13:00至15:00；通过深圳证券交易所互联网投 票系统投票的具体时间为：2025年9月16日9:15至15:00。 5、会议的召开方式：本次股东大会以现场表决与网络投票相结合的方式召 开： （1）本次股东大会 ...

证券代码：002250 证券简称：联化科技 公告编号：2025-036 联化科技股份有限公司 第八届监事会第十二次会议决议公告 本公司及监事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 特此公告。 联化科技股份有限公司监事会 《2025年半年度报告摘要》刊登于《证券时报》《上海证券报》和巨潮资讯 网（www.cninfo.com.cn）（公告编号：2025-037）。 二、会议以3票同意，0票反对，0票弃权的表决结果，审议并通过《关于2025 年半年度计提资产减值准备的议案》，并发表如下审核意见： 公司根据《企业会计准则》和公司相关会计政策等的规定计提资产减值准备， 符合公司实际情况，经过资产减值准备计提后更能公允的反映公司的资产状况、 财务状况以及经营成果，不存在损害公司及全体股东、特别是中小股东利益的情 形，公司董事会就该项议案的决策程序符合相关法律法规的有关规定，公司监事 会同意本次计提资产减值准备。 具体详见公司同日刊登于《证券时报》《上海证券报》和巨潮资讯网 （www.cninfo.com.cn）的《关于2025年半年度计提资产减值准备的公告》（公告 编号：2 ...

证券代码：002250 证券简称：联化科技 公告编号：2025-035 联化科技股份有限公司 第八届董事会第二十五次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 联化科技股份有限公司（以下简称"公司"）第八届董事会第二十五次会议 通知于2025年8月15日以电子邮件方式发出。会议于2025年8月26日在联化科技会 议室以现场与通讯表决相结合的方式召开。会议应出席董事7人，实际出席董事7 人。公司监事、高级管理人员列席了本次会议，会议由董事长王萍女士召集和主 持，符合《公司法》《证券法》等法律法规、部门规章、规范性文件及《公司章 程》的有关规定。会议形成如下决议： 一、会议以7票同意，0票反对，0票弃权的表决结果，审议并通过《2025年 半年度报告及其摘要》。 《2025年半年度报告》全文刊登于巨潮资讯网（www.cninfo.com.cn）。 《2025年半年度报告摘要》刊登于《证券时报》《上海证券报》和巨潮资讯 网（www.cninfo.com.cn）（公告编号：2025-037）。 二、会议以7票同意，0票反对，0票弃权的表决结果，审议并通 ...

Financial Performance - The company's operating revenue for the reporting period was ¥3,149,665,798.40, representing a 5.76% increase compared to ¥2,978,007,248.11 in the same period last year[23]. - Net profit attributable to shareholders reached ¥223,936,667.63, a significant increase of 1,481.94% from ¥14,155,862.09 in the previous year[23]. - The net profit after deducting non-recurring gains and losses was ¥208,250,354.93, up 1,534.47% from ¥12,741,185.72 year-on-year[23]. - The basic and diluted earnings per share were both ¥0.2457, reflecting a 1,505.88% increase from ¥0.0153 in the same period last year[23]. - The company's total assets at the end of the reporting period were ¥13,636,331,477.64, a decrease of 1.15% from ¥13,795,078,251.29 at the end of the previous year[23]. - The net assets attributable to shareholders increased to ¥6,574,371,031.88, marking a 1.55% rise from ¥6,473,934,873.23 at the end of the previous year[23]. - The company's total current assets as of June 30, 2025, amounted to CNY 5,658,974,865.45, an increase from CNY 5,456,943,622.05 at the beginning of the period, reflecting a growth of approximately 3.9%[153]. - Total liabilities decreased to CNY 6,643,091,178.52 from CNY 6,918,771,100.14, showing a reduction of about 4.0%[155]. - The company's total equity increased to CNY 6,993,240,299.12 from CNY 6,876,307,151.15, reflecting a growth of approximately 1.7%[155]. Business Segments - The company operates in four main business segments: plant protection, pharmaceuticals, functional chemicals, and equipment and engineering services[30]. - The pharmaceutical segment has seen significant growth, primarily due to concentrated shipments, enhancing the overall operational efficiency[41]. - The functional chemicals segment is focusing on developing products for personal care, battery chemicals, and new energy, responding to the growing market demand[37]. - The industrial heat exchange energy-saving equipment segment has maintained a strong market share, particularly in the petrochemical and fine chemical industries[40]. Research and Development - The company has established a multi-tiered R&D platform to enhance its core technology fields and improve market competitiveness for customized and proprietary products[53]. - The core R&D teams in the plant protection and pharmaceutical divisions have a significant proportion of employees with master's or doctoral degrees, ensuring strong technical innovation capabilities[55]. - The R&D team is increasing efforts in self-owned product development, optimizing production processes towards cleaner and recyclable methods[56]. - Breakthroughs in new technology research include the successful application of efficient ligand catalysis and palladium recovery technology in commercial production, significantly reducing precious metal usage and production costs[56]. - The company has established a biomanufacturing platform and made progress in developing green enzyme catalysis technologies, with multiple projects validated in mid-2025[57]. Compliance and Governance - The management team guarantees the accuracy and completeness of the financial report for the first half of 2025[4]. - The report is prepared in accordance with the relevant laws and regulations governing public companies in China[4]. - The company emphasizes compliance with the disclosure requirements of the chemical industry as per the Shenzhen Stock Exchange guidelines[5]. - The semi-annual financial report has not been audited[112]. - The company has included 8 subsidiaries in the legally mandated environmental information disclosure list[105]. Risks and Challenges - The company faced risks from macroeconomic fluctuations, which impacted customer demand and sales[90]. - Environmental safety risks were highlighted due to the use of hazardous chemicals in production, necessitating higher costs for compliance[91]. - Raw material price volatility poses a significant risk, with raw material costs comprising a large portion of overall expenses[92]. - Management risks arise from the geographical dispersion of factories, requiring targeted resource allocation for effective oversight[96]. Shareholder Information - The company completed a share buyback of 11,459,900 shares, representing 1.26% of the total share capital, with a total transaction amount of 79,996,638.00 RMB[140]. - The largest shareholder, Mu Jinxiang, holds 25.74% of the shares, totaling 234,535,853 shares[143]. - The company has 72,327 common stock shareholders as of the end of the reporting period[143]. Cash Flow and Investments - The net cash flow from operating activities decreased by 47.42% to ¥354,331,658.22, down from ¥673,897,924.48 in the previous year[69]. - The company reported a significant increase in accounts receivable financing, which rose by 112.04% to ¥356,571,111.07 from ¥168,162,515.24[69]. - The company reported a net cash outflow from investing activities of ¥172.24 million in the first half of 2025, compared to a net outflow of ¥372.86 million in the first half of 2024[164]. Corporate Strategy - The company is committed to sustainable development, continuously improving R&D investment and operational efficiency while adhering to environmental protection standards[41]. - The company aims to enhance operational efficiency and improve product structure to increase gross profit margins in its main business segments[72]. - The company plans to enhance product variety and reduce reliance on single raw materials to mitigate risks[93].

Investment Rating - The report maintains a "Buy" rating for the company with a target price of 86.10 CNY, based on a projected PE ratio of 21 times for 2025 [2][5]. Core Insights - The company's earnings per share (EPS) are forecasted to be 4.10 CNY, 4.89 CNY, and 5.94 CNY for the years 2025, 2026, and 2027 respectively, indicating a strong recovery and growth trajectory [2]. - The report highlights significant improvements in operational performance, with a notable increase in revenue and net profit in the second quarter, driven by structural optimization and enhanced profitability [10]. - The company has strengthened its risk control capabilities in overseas operations, achieving a net operating cash flow of 960 million CNY in the second quarter, marking the best quarterly performance in nearly two years [10]. Financial Information Summary - Revenue projections for the company are as follows: - 2023: 11,485 million CNY - 2024: 13,296 million CNY (15.8% YoY growth) - 2025: 15,073 million CNY (13.4% YoY growth) - 2026: 17,376 million CNY (15.3% YoY growth) - 2027: 19,900 million CNY (14.5% YoY growth) [4] - The company's gross profit margin is expected to improve from 21.2% in 2023 to 21.9% in 2027, reflecting ongoing structural enhancements [4]. - The net profit attributable to the parent company is projected to recover significantly, with estimates of 1,152 million CNY in 2025, 1,372 million CNY in 2026, and 1,668 million CNY in 2027, showcasing a strong growth trend [4].

Group 1 - The pesticide sector is experiencing a rebound, with Meibang Co., Ltd. hitting the daily limit up [1] - Other companies in the sector, such as Shanshui Technology, Yingtai Biology, Yangnong Chemical, Lianhua Technology, and Zhongnong United, are also seeing increases in their stock prices [1]

Group 1: Market Performance - The agricultural chemical sector rose by 1.36% on August 21, with Meibang Co., Ltd. leading the gains [1] - The Shanghai Composite Index closed at 3771.1, up 0.13%, while the Shenzhen Component Index closed at 11919.76, down 0.06% [1] Group 2: Individual Stock Performance - Meibang Co., Ltd. (code: 605033) closed at 23.77, with a 10.00% increase and a trading volume of 122,900 shares, amounting to a transaction value of 283 million [1] - Hong Sifang (code: 603395) closed at 36.46, up 6.36%, with a trading volume of 156,100 shares [1] - New Yangfeng (code: 000902) closed at 15.21, up 6.29%, with a trading volume of 684,200 shares, totaling 1.035 billion [1] - Other notable performers include Stanley (code: 002588) with a 5.40% increase and Yangnong Chemical (code: 600486) with a 5.33% increase [1] Group 3: Fund Flow Analysis - The agricultural chemical sector experienced a net outflow of 10.82 million from institutional investors, while retail investors saw a net outflow of 60.06 million [2] - The sector attracted a net inflow of 70.88 million from speculative funds [2] Group 4: Detailed Fund Flow for Selected Stocks - Limin Co., Ltd. (code: 002734) had a net inflow of 1.29 billion from institutional investors, but a net outflow of 1.34 billion from retail investors [3] - Yun Tianhua (code: 600096) saw a net inflow of 99.11 million from institutional investors, with a net outflow of 1.17 billion from retail investors [3] - Meibang Co., Ltd. (code: 605033) had a net inflow of 69.47 million from institutional investors, but a significant net outflow from both speculative and retail investors [3]

Group 1 - The agricultural chemical sector experienced a significant upward movement on August 21, with Meibang Co., Ltd. hitting the daily limit up [1] - Other companies in the sector, including Yara International, New Yangfeng, Stanley, Yangnong Chemical, and Lianhua Technology, also saw their stock prices rise in response [1]